Inventor · disambiguated record
Johannes Wilhelmus John F. Thuring
Also filed as: THURING JOHANNES WILHELMUS J · THURING JOHANNES WILHELMUS J F · THURING JOHANNES WILHELMUS JOHN F · THURING JOHANNES WILHELMUS JOHN FITZGERALD
27 granted patents·14 pending applications·50 citations·filing 2007–2023
94Inventor score
Files withJANSSEN PHARMACEUTICA NV24JANSSEN BIOTECH INC5THURING JOHANNES WILHELMUS JOHN F5THURING JOHANNES WILHELMUS J3MACDONALD GREGOR JAMES2
Top patents by PatentIndex Score
41 records- 0192US11702441B2Spirobicyclic analoguesJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Jul 18, 2023·2 cites·2 claims
- 0292US11059850B2Spirobicyclic analoguesJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Jul 13, 2021·8 cites·21 claims
- 0391US10653711B26-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted May 19, 2020·6 cites·18 claims
- 0491US8497270B2Macrocyclic integrase inhibitorsTHURING JOHANNES WILHELMUS J·Filed 2010·Granted Jul 30, 2013·13 cites·15 claims
- 0590US10954214B2Pyrazole derivatives as MALT1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Mar 23, 2021·5 cites·37 claims
- 0684US12145961B2Spirobicyclic analoguesJANSSEN PHARMACEUTICA NV·Filed 2023·Granted Nov 19, 2024·0 cites·1 claims
- 0783US11318157B26-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted May 3, 2022·1 cites·4 claims
- 0881US8143419B2Trisubstituted 1,2,4-triazolesTHURING JOHANNES WILHELMUS JOHN F·Filed 2007·Granted Mar 27, 2012·8 cites·11 claims
- 0977US2024124493A1Monocyclic And Bicyclic Ring System Substituted Carbanucleoside Analogues For Use As PRMT5 InhibitorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 1077US2023330127A16-6 bicyclic aromatic ring substituted nucleoside analogues for use as prmt5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 1174US11883367B26-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Jan 30, 2024·0 cites·19 claims
- 1274US11597746B2Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2019·Granted Mar 7, 2023·1 cites·53 claims
- 1374US9388175B22-aniline-4-aryl substituted thiazole derivativesTHURING JOHANNES WILHELMUS JOHN F·Filed 2008·Granted Jul 12, 2016·4 cites·4 claims
- 1474US8778974B2Trisubstituted 1,2,4 triazolesMACDONALD GREGOR JAMES·Filed 2009·Granted Jul 15, 2014·2 cites·4 claims
- 1573US2023287034A1Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 1668US11993614B2Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted May 28, 2024·0 cites·16 claims
- 1767US2023146410A1Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 1864US12077521B2Pyrazole derivatives as MALT1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Sep 3, 2024·0 cites·18 claims
- 1960US11098062B2Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Aug 24, 2021·0 cites·6 claims
- 2059US11492367B2Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2018·Granted Nov 8, 2022·0 cites·19 claims
- 2158US2025197392A1Crystalline forms of an inhibitor of the menin/mll interactionJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 2255US9139523B25-HT2B receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Sep 22, 2015·0 cites·1 claims
- 2355US8404851B21,3,5-trisubstituted triazole derivativeTHURING JOHANNES WILHELMUS JOHN F·Filed 2008·Granted Mar 26, 2013·0 cites·6 claims
- 2455US2025302840A1Combination therapiesJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 2555US2025333421A1Pyridazines or 1,2,4-triazines substituted by spirocyclic aminesJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 2655US2023250096A1SUBSTITUTED PHENYL-1H-PYRROLO[2,3-c] PYRIDINE DERIVATIVESJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 2755US2024417405A1Substituted Spiro DerivativesJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 2854US12473295B2Substituted straight chain spiro derivativesJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Nov 18, 2025·0 cites·20 claims
- 2953US8703958B25-HT2B receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 22, 2014·0 cites·5 claims
- 3053US2024261292A1Combination therapiesJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 3152US12404260B2Pyridine rings containing derivatives as MALT1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Sep 2, 2025·0 cites·9 claims
- 3252US8779158B2Trisubstituted pyrazoles as acetylcholine receptor modulatorsTHURING JOHANNES WILHELMUS JOHN F·Filed 2009·Granted Jul 15, 2014·0 cites·7 claims
- 3350US8440701B2Trisubstituted 1,2,4 triazolesTHURING JOHANNES WILHELMUS JOHN F·Filed 2008·Granted May 14, 2013·0 cites·8 claims
- 3450US2021009630A1Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2018·Application pending·0 cites
- 3547US2022275018A1Novel spirobicyclic intermediatesJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
- 3644US10898504B2Substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jan 26, 2021·0 cites·17 claims
- 3743US8716293B2Macrocyclic integrase inhibitorsTHURING JOHANNES WILHELMUS J·Filed 2011·Granted May 6, 2014·0 cites·17 claims
- 3839US2013296330A1Macrocyclic integrase inhibitors for use in the treatment of feline immunodeficiency virusTHURING JOHANNES WILHELMUS J·Filed 2012·Application pending·0 cites
- 3937US8791144B2Substituted N-phenyl-1-(4-Pyridinyl)-1H-pyrazol-3-aminesMACDONALD GREGOR JAMES·Filed 2010·Granted Jul 29, 2014·0 cites·6 claims
- 4036US2014357577A1HIV Membrane Fusion InhibitorsJANSSEN R & D LTD·Filed 2012·Application pending·0 cites
- 4128US8592429B25-amino-4-hydroxypentoyl amidesKALAYANOV GENADIY·Filed 2010·Granted Nov 26, 2013·0 cites·21 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →